Reliability and validity of proxy-SSPedi and mini-SSPedi in pediatric patients 2-7 years receiving cancer treatments

Reliability and validity of proxy-SSPedi and mini-SSPedi in pediatric patients 2-7 years receiving cancer treatments

Background: Symptom Screening in Pediatrics Tool (SSPedi) was developed for symptom screening by children 8-18 years. Objectives were to evaluate the reliability and validity of proxy-SSPedi and self-report mini-SSPedi for younger children. Methods: This multi-center study enrolled guardians of chil...

Full description

Bibliographic Details
Main Authors: Dupuis, L.L (Author), Johnston, D.L (Author), Kuczynski, S. (Author), Mairs, M. (Author), Patel, S. (Author), Schechter, T. (Author), Sung, L. (Author), Tomlinson, D. (Author), Tomlinson, G.A (Author), Vettese, E. (Author)
Format: Article
Language:English
Published: BioMed Central Ltd 2022
Subjects:
Children
Hematopoietic stem cell transplantation
Oncology
Proxy
Reliability
Responsiveness
Symptom screening
Validity
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items